Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
12/08/202415:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TECHBio Techne Corporation
12/08/202415:08Business WirePublic Disclosure of Hospital Errors, CANDOR System Get Giant Boost From Medicare/Medicaid
12/08/202415:07Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:MDRXVeradigm Inc
12/08/202415:07Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AUGXAugmedix Inc
12/08/202415:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALNYAlnylam Pharmaceuticals Inc
12/08/202415:07Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:FBGXUBS AG FI Enhanced Large Cap Growth
12/08/202415:07Edgar (US Regulatory)Form 8-K - Current reportAMEX:STXSStereotaxis Inc
12/08/202415:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:AGROAdecoagro SA
12/08/202415:07Edgar (US Regulatory)Form 424B8 - Prospectus filed pursuant to Rule 424(b)(8)AMEX:AMJJP Morgan Alerian MLP
12/08/202415:07PR Newswire (Canada)Restaurant Brands International Inc. Announces Receipt of Exchange Notice, Intent to Use Common Shares to Satisfy Exchange and Commencement of Secondary Offering of Common SharesNYSE:QSRRestaurant Brands International Inc
12/08/202415:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VRDNViridian Therapeutics Inc
12/08/202415:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:TWOHDTwo Hands Corporation (PK)
12/08/202415:05Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNYSE:MROMarathon Oil Corp
12/08/202415:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:WHLRPWheeler Real Estate Investment Trust Inc
12/08/202415:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:DRRXDurect Corp
12/08/202415:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QSIQuantum Si Inc
12/08/202415:05GlobeNewswire Inc.Surrozen Provides Second Quarter 2024 Financial Results and Business UpdateNASDAQ:SRZNSurrozen Inc
12/08/202415:05GlobeNewswire Inc.Spectral AI Announces 2024 Second Quarter Financial ResultsNASDAQ:MDAIWSpectral AI Inc
12/08/202415:05Business WireProcore Announces Investor Call with CRO Larry StackNYSE:PCORProcore Technologies Inc
12/08/202415:05Business WireVicarious Surgical Reports Second Quarter 2024 Financial ResultsNYSE:RBOTVicarious Surgical Inc
12/08/202415:05Business WireWerner Enterprises Announces Quarterly DividendNASDAQ:WERNWerner Enterprises Inc
12/08/202415:05Business WireAmeresco and the City of Somersworth Break Ground on New Hampshire’s First Landfill Solar Project to be Placed on a Superfund SiteNYSE:AMRCAmeresco Inc
12/08/202415:05PR Newswire (US)iRobot Names Michael J. Loparco to Board of DirectorsNASDAQ:IRBTiRobot Corporation
12/08/202415:05GlobeNewswire Inc.TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue GuidanceNASDAQ:TELATELA Bio Inc
12/08/202415:05Business WireFormer Vice Chairman of Bell Canada Wade Oosterman Joins Calix Board of DirectorsNYSE:CALXCalix Inc
12/08/202415:05Business WireBrenmiller Energy Ltd. Announces Receipt of Nasdaq Minimum Bid Price NotificationNASDAQ:BNRGBrenmiller Energy Ltd
12/08/202415:05Business WireZura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding WarrantsNASDAQ:ZURAZura Bio Ltd
12/08/202415:05Business WireCardea Successfully Closes $15 Million Convertible Note FinancingNASDAQ:GBBKGlobal Blockchain Acquisition Corporation
12/08/202415:05GlobeNewswire Inc.Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate HighlightsNASDAQ:ADVMAdverum Biotechnologies Inc
12/08/202415:05PR Newswire (US)Kyverna Therapeutics Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Progressive Myasthenia GravisNASDAQ:KYTXKyverna Therapeutics Inc